Gras et al., 2007 - Google Patents
Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safetyGras et al., 2007
View HTML- Document ID
- 5931303444005219510
- Author
- Gras D
- Böcker D
- Lunati M
- Wellens H
- Calvert M
- Freemantle N
- Gervais R
- Kappenberger L
- Tavazzi L
- Erdmann E
- Cleland J
- Daubert J
- Publication year
- Publication venue
- Europace
External Links
Snippet
Aims To assess procedural characteristics and adjudicated procedure-related (≤ 30 days) major adverse events among patients who underwent cardiac resynchronization therapy (CRT) implantation in the CARE-HF study. The CARE-HF study shows that CRT improves …
- 238000009125 cardiac resynchronization therapy 0 title abstract description 77
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
- A61N1/3684—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions for stimulating the heart at multiple sites of the ventricle or the atrium, e.g. biventricular stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation, e.g. heart pace-makers
- A61N1/372—Arrangements in connection with the implantation of stimulators
- A61N1/37211—Means for communicating with stimulators
- A61N1/37252—Details of algorithms or data aspects of communicaton system, e.g. handshaking, transmitting specific data or segmenting data
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gras et al. | Implantation of cardiac resynchronization therapy systems in the CARE-HF trial: procedural success rate and safety | |
| Wang et al. | Randomized trial of left bundle branch vs biventricular pacing for cardiac resynchronization therapy | |
| Niazi et al. | Safety and efficacy of multipoint pacing in cardiac resynchronization therapy: the multipoint pacing trial | |
| Keene et al. | His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: insights from a large international observational study | |
| Tomassoni et al. | Postoperative performance of the Quartet® left ventricular heart lead | |
| Saxon et al. | Influence of left ventricular lead location on outcomes in the COMPANION study | |
| Barba-Pichardo et al. | Ventricular resynchronization therapy by direct His-bundle pacing using an internal cardioverter defibrillator | |
| Gillis et al. | HRS/ACCF expert consensus statement on pacemaker device and mode selection | |
| Occhetta et al. | Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing | |
| Leclercq et al. | A randomized comparison of triple-site versus dual-site ventricular stimulation in patients with congestive heart failure | |
| Carabelli et al. | European experience with a first totally leadless cardiac resynchronization therapy pacemaker system | |
| Forleo et al. | Clinical and procedural outcome of patients implanted with a quadripolar left ventricular lead: early results of a prospective multicenter study | |
| Dong et al. | Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis | |
| Shetty et al. | Use of a quadripolar left ventricular lead to achieve successful implantation in patients with previous failed attempts at cardiac resynchronization therapy | |
| Boriani et al. | Cardiac resynchronization therapy with a quadripolar electrode lead decreases complications at 6 months: results of the MORE-CRT randomized trial | |
| Lenarczyk et al. | Triple-site biventricular pacing in patients undergoing cardiac resynchronization therapy: a feasibility study | |
| Akerström et al. | Estimation of the effects of multipoint pacing on battery longevity in routine clinical practice | |
| De Leon et al. | Adopting permanent His bundle pacing: learning curves and medium-term outcomes | |
| Kato et al. | Efficacy of his bundle pacing on LV relaxation and clinical improvement in HF and LBBB | |
| Senes et al. | Is His‐optimized superior to conventional cardiac resynchronization therapy in improving heart failure? Results from a propensity‐matched study | |
| Piccini et al. | Patient selection, pacing indications, and subsequent outcomes with de novo leadless single-chamber VVI pacing | |
| Kolb et al. | Safety of mid-septal electrode placement in implantable cardioverter defibrillator recipients—Results of the SPICE (Septal Positioning of ventricular ICD Electrodes) study | |
| Ziacchi et al. | Bipolar active fixation left ventricular lead or quadripolar passive fixation lead? An Italian multicenter experience | |
| Gras et al. | Optimal stimulation of the left ventricle | |
| Cazeau et al. | Cardiac resynchronization therapy |